Asbract
Understanding the molecular mechanisms of steroid hormone action requires assays that measure rates of ligand dissociation and receptor degradation. Ligand dissociation is a pseudo-first order reaction of a high affinity [3H]-labeled ligand. Receptor turnover as described here is the rate of degradation of a radiolabeled receptor. The methods make use of transient expression of a nuclear receptor in cultured cells and are applicable to all nuclear receptors. Rates of ligand dissociation and receptor degradation provided the first insight into the interdomain interactions of the androgen receptor and the molecular basis for the phenotypic effects of naturally occurring androgen receptor loss-of-function germline muta tions and gain-of-function somatic mutations, and for the potency differences between the biologically active androgens, testosterone, and dihydrotestosterone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wilson, E. M., and French, F. S. (1976) Binding properties of androgen receptors: evidence for identical receptors in rat testis, epididymis, and prostate. J. Biol. Chem. 251, 5620–5629.
Wilson, E. M., and French, F. S. (1979) Effects of proteases and protease inhibitors on the 4.5S and 8S androgen receptor. J. Biol. Chem. 254, 6310–6319.
Lubahn, D. B., Joseph, D. R., Sullivan, P. M., Willard, H. F., French, F. S., and Wilson, E. M. (1988) Cloning of human androgen receptor cDNA and localization to the X chromosome. Science 240, 327–330.
Lubahn, D. B., Joseph, D. R., Sar, M., Tan, J. A., Higgs, H. N., Larson, R. E., French, F. S., and Wilson, E. M. (1988) The human andro- gen receptor: complementary DNA cloning, sequence analysis and gene expression in prostate. Mol. Endocrinol. 2, 1265–1275.
Chang, C. S., Kokontis, J., and Liao, S. T. (1988) Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240, 324–326.
Tan, J. A., Joseph, D. R., Quarmby, V. E., Lubahn, D. B., Sar, M., French, F. S., and Wilson, E. M. (1988) The rat androgen receptor: primary structure, autoregulation of its messenger RNA and immunocytochemi-cal localization of the receptor protein. Mol. Endocrinol. 2, 1276–1285.
Langley, E., Zhou, Z. X., and Wilson, E. M. (1995) Evidence for an antiparallel orientation of the ligand activated human andro- gen receptor dimer. J. Biol. Chem. 270, 29983–29990.
Langley, E., Kemppainen, J. A., and Wilson, E. M. (1998) Intermolecular NH2−/ carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J. Biol. Chem. 273, 92–101.
He, B., Kemppainen, J. A., and Wilson, E. M. (2000) FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275, 22986–22994.
He, B., Bowen, N. T., Minges, J. T., and Wilson, E. M (2001) Androgen-induced NH2- and carboxyl-terminal interaction inhibits p160 coactivator recruitment by activation function 2. J. Biol. Chem. 276, 42293–42301.
Zhou, Z. X., Lane, M. V., Kemppainen, J. A., French, F. S., and Wilson, E. M. (1995) Specificity of ligand dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9, 208–218.
Kemppainen, J. A., Langley, E., Wong, C. I., Bobseine, K., Kelce, W. R., and Wilson, E. M. (1999) Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol. Endocrinol. 13, 440–454.
Askew, E. B., Gampe, R. T., Stanley, T. B., Faggart, J. L., and Wilson, E. M. (2007) Modulation of androgen receptor activation function 2 by testosterone and dihydrotesto-sterone. J. Biol. Chem. 282, 25801–25816.
Kemppainen, J. A., Lane, M. V., Sar, M., and Wilson, E. M. (1992) Androgen receptor phos-phorylation, turnover, nuclear transport and transcriptional activation: specificity for steroids and antihormones. J. Biol. Chem. 267, 968–974.
He, B., Kemppainen, J. A., Voegel, J. J., Gronemeyer, H., and Wilson, E. M. (1999) Activation function 2 in the human andro-gen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain. J. Biol. Chem. 274, 37219–37225.
Quigley, C. A., Tan, J. A., He, B., Zhou, Z. X., Mebarki, F., Morel, Y., Forest, M., Chatelain, P. , Ritzen, E. M., French, F. S., and Wilson, E. M. (2004) Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH2- and car-boxyl-terminal interaction. Mech. Ageing Dev. 125, 683–695.
He, B., Gampe, R. T., Hnat, A. T., Faggart, J. L., Minges, J. T., French, F. S., and Wilson, E. M. (2006) Probing the functional link between androgen receptor coactivator and ligand binding sites in prostate cancer and androgen insensitivity. J. Biol. Chem. 281, 6648–6663.
Quigley, C. A., De Bellis, A., Marschke, K. B., El-Awady, M. K., Wilson, E. M., and French, F. S. (1995) Androgen receptor defects: historical, clinical and molecular perspectives. Endocrine Reviews 16, 271–321.
Quarmby, V. E., Yarbrough, W. G., Lubahn, D. B., French, F. S., and Wilson, E.M. (1990) Autologous down regulation of androgen receptor messenger ribonucleic acid. Mol. Endocrinol. 4, 22–28.
Bai, S., and Wilson, E. M. (2008) EGF dependent phosphorylation and ubiquitinyla-tion of MAGE-11 regulates its interaction with the androgen receptor. Mol. Cell. Biol. 28, in press
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wilson, E.M. (2009). Methods for Measuring Ligand Dissociation and Nuclear Receptor Turnover in Whole Cells. In: McEwan, I.J. (eds) The Nuclear Receptor Superfamily. Methods in Molecular Biology™, vol 505. Humana Press. https://doi.org/10.1007/978-1-60327-575-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-60327-575-0_2
Publisher Name: Humana Press
Print ISBN: 978-1-60327-574-3
Online ISBN: 978-1-60327-575-0
eBook Packages: Springer Protocols